Natto Supplementation to Prevent Loss of Bone Mass in Women Immediately After Menopause

NCT00290212 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

304

Enrollment

OTHER

Sponsor class

Conditions

Perimenopausal Bone Loss

Interventions

DRUG: Natto capsules (food suppl.) cont. 360 microg. vit K2/day
DRUG: Placebo capsules

Sponsor

University Hospital of North Norway

Collaborators

[object Object]
[object Object]
[object Object]